China's national health and Family Planning Commission held a regular press conference on September 10. Qin Huaijin, director of the science and Education Department of the national health and Family Planning Commission, pointed out that since the "12th Five Year Plan", China has closely focused on the national strategy and people's health needs, organized and implemented a number of key projects in the field of medicine and health, such as major scientific and technological projects. The state's financial input totaled nearly 30 billion yuan, and a large number of achievements with international standards have been produced.

One hundred years may be just a flick of a finger in the vast history, but the hundred years since the founding of the Communist Party of China have witnessed the vicissitudes of China, led the great changes of the Chinese nation and achieved the glory of the Chinese history. In all walks of life, hundreds of boats compete with each other and are in full bloom. China's pharmaceutical industry is no exception. In the eventful years, earth shaking changes have taken place. Let's touch the pulse of innovation and Reform in China's pharmaceutical industry and feel the past, present and future of China's pharmaceutical industry.

Since the birth of the world's first targeted antibody drug Herceptin (trastuzumab) and the first small molecule targeted drug glipizide (imatinib), targeted drugs have played a unique advantage and role in the diagnosis and treatment of diseases, especially for major diseases such as cancer, cardiovascular disease and infection. They play an indispensable role and bring great hope to patients. Targeted drugs have changed the treatment of diseases, and mankind has entered a new era of personalized and precise treatment.